COVID19 | NTAGI approves Serum Institute of India’s Covovax for the 12-17 age group: Reports
The post NTAGI approves Serum Institute of India’s Covovax for the 12-17 age group: Reports appeared first on Jammu Kashmir Latest News | Tourism | Breaking News J&K.